Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
  Overview | Kerydin | AN2718 | AN2728 | AN2898 | AN3365 | Animal Health | Neglected Diseases | Clinical Trials
    Pipeline - 2690

We believe the unique characteristics of boron allow us to engineer novel product candidates that target a broad range of diseases and drive a rapid and efficient drug development process. Learn more about Kerydin
Learn more about AN2728



 

Kerydin™ (tavaborole) topical solution, 5% has received FDA approval. Please click here for prescribing information.

For more information about Kerydin, please email medicalinfo@anacor.com, or call toll free 1 (844) 4ANACOR and select option 4 for Medical Information.

spacer